Lipids and Lipid Disorders

Contributing journals to this collection:
JAMA & Archives Journals

Citations 371-380 of 550 total displayed.

Past content

Epidemiology and Biostatistics
Risk Factors for Incident Retinopathy in a Diabetic and Nondiabetic Population: The Hoorn Study

Hendrik A. van Leiden; Jacqueline M. Dekker; Annette C. Moll; Giel Nijpels; Robert J. Heine; Lex M. Bouter; Coen D. A. Stehouwer; Bettine C. P. Polak
Arch Ophthalmol 2003; 121: 245-251. [Abstract] [Full text] [PDF]  

Review Articles
Cardiovascular Disease in Type 2 Diabetes Mellitus: Current Management Guidelines

Arshag D. Mooradian
Arch Intern Med 2003; 163: 33-40. [Abstract] [Full text] [PDF]  

Original Investigations
Long-term Compliance With Lipid-Lowering Medication After Genetic Screening for Familial Hypercholesterolemia

Marina A. W. Umans-Eckenhausen; Joep C. Defesche; Marjel J. van Dam; John J. P. Kastelein
Arch Intern Med 2003; 163: 65-68. [Abstract] [Full text] [PDF]  

Original Contributions
Fish Consumption and Risk of Stroke in Men

Ka He; Eric B. Rimm; Anwar Merchant; Bernard A. Rosner; Meir J. Stampfer; Walter C. Willett; Alberto Ascherio
JAMA 2002; 288: 3130-3136. [Abstract] [Full text] [PDF]  

Original Contributions
Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)

The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group
JAMA 2002; 288: 2998-3007. [Abstract] [Full text] [PDF]  

Editorials
The ALLHAT Lipid Lowering Trial—Less Is Less

Richard C. Pasternak
JAMA 2002; 288: 3042-3044. [Extract] [Full text] [PDF]  

Original Investigations
Risk Factors for Coronary Heart Disease in African Americans: The Atherosclerosis Risk in Communities Study, 1987-1997

Daniel W. Jones; Lloyd E. Chambless; Aaron R. Folsom; Gerardo Heiss; Richard G. Hutchinson; A. Richey Sharrett; Moyses Szklo; Herman A. Taylor Jr
Arch Intern Med 2002; 162: 2565-2571. [Abstract] [Full text] [PDF]  

Original Investigations
Diabetes, Plasma Insulin, and Cardiovascular Disease: Subgroup Analysis From the Department of Veterans Affairs High-Density Lipoprotein Intervention Trial (VA-HIT)

Hanna Bloomfield Rubins; Sander J. Robins; Dorothea Collins; David B. Nelson; Marshall B. Elam; Ernst J. Schaefer; Fred H. Faas; James W. Anderson; for the VA-HIT Study Group
Arch Intern Med 2002; 162: 2597-2604. [Abstract] [Full text] [PDF]  

Clinical Cardiology
Optimal Diets for Prevention of Coronary Heart Disease

Frank B. Hu; Walter C. Willett
JAMA 2002; 288: 2569-2578. [Abstract] [Full text] [PDF]  

Original Articles
An Assessment of the Independent Effects of Olanzapine and Risperidone Exposure on the Risk of Hyperlipidemia in Schizophrenic Patients

Carol E. Koro; Donald O. Fedder; Gilbert J. L'Italien; Sheila Weiss; Laurence S. Magder; Julie Kreyenbuhl; Dennis Revicki; Robert W. Buchanan
Arch Gen Psychiatry 2002; 59: 1021-1026. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55